55 related articles for article (PubMed ID: 7786399)
1. Novel quinone antiproliferative inhibitors of phosphatidylinositol-3-kinase.
Frew T; Powis G; Berggren M; Gallegos A; Abraham RT; Ashendel CL; Zalkow LH; Hudson C; Gruszecka-Kowalik E; Burgess EM
Anticancer Drug Des; 1995 Jun; 10(4):347-59. PubMed ID: 7786399
[TBL] [Abstract][Full Text] [Related]
2. Advances with phospholipid signalling as a target for anticancer drug development.
Powis G; Berggren M; Gallegos A; Frew T; Hill S; Kozikowski A; Bonjouklian R; Zalkow L; Abraham R; Ashendel C
Acta Biochim Pol; 1995; 42(4):395-403. PubMed ID: 8852330
[TBL] [Abstract][Full Text] [Related]
3. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes.
Herrera-Velit P; Reiner NE
J Immunol; 1996 Feb; 156(3):1157-65. PubMed ID: 8557993
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
6. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
8. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.
Gold MR; Aebersold R
J Immunol; 1994 Jan; 152(1):42-50. PubMed ID: 8254204
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy.
Rucci N; Recchia I; Angelucci A; Alamanou M; Del Fattore A; Fortunati D; Susa M; Fabbro D; Bologna M; Teti A
J Pharmacol Exp Ther; 2006 Jul; 318(1):161-72. PubMed ID: 16627750
[TBL] [Abstract][Full Text] [Related]
10. Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase.
Lemke LE; Paine-Murrieta GD; Taylor CW; Powis G
Cancer Chemother Pharmacol; 1999; 44(6):491-7. PubMed ID: 10550570
[TBL] [Abstract][Full Text] [Related]
11. Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas.
Takagi H; Imai A; Furui T; Horibe S; Fuseya T; Tamaya T
Gynecol Oncol; 1995 Jul; 58(1):110-5. PubMed ID: 7789876
[TBL] [Abstract][Full Text] [Related]
12. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
Teng JM; Liu XR; Mills GB; Dupont B
J Immunol; 1996 May; 156(9):3222-32. PubMed ID: 8617944
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological study of stem-cell-factor-induced mast cell histamine release with kinase inhibitors.
Nagai S; Kitani S; Hirai K; Takaishi T; Nakajima K; Kihara H; Nonomura Y; Ito K; Morita Y
Biochem Biophys Res Commun; 1995 Mar; 208(2):576-81. PubMed ID: 7535052
[TBL] [Abstract][Full Text] [Related]
14. Oxidants depress the synthesis of phosphatidylinositol 4,5-bisphosphate in heart sarcolemma.
Mesaeli N; Tappia PS; Suzuki S; Dhalla NS; Panagia V
Arch Biochem Biophys; 2000 Oct; 382(1):48-56. PubMed ID: 11051096
[TBL] [Abstract][Full Text] [Related]
15. Activation of a membrane-associated phosphatidylinositol kinase through tyrosine-protein phosphorylation by naphthoquinones and orthovanadate.
Chen YX; Yang DC; Brown AB; Jeng Y; Tatoyan A; Chan TM
Arch Biochem Biophys; 1990 Nov; 283(1):184-92. PubMed ID: 1700668
[TBL] [Abstract][Full Text] [Related]
16. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
17. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
[TBL] [Abstract][Full Text] [Related]
18. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
19. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G
Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase.
Creemer LC; Kirst HA; Vlahos CJ; Schultz RM
J Med Chem; 1996 Dec; 39(25):5021-4. PubMed ID: 8960564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]